α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s disease
Tracy A. Cole, Hien Zhao, Timothy J. Collier et al. · JCI Insight · 2021
Full textCC BY
Clinical Neurology
Filters3 filters applied
Status
- No notice
- From publisher notices and Retraction Watch. Not checked means nobody has looked yet.
Year
Readable here
2 papersQuestions on this topic
Pattern of Regional Cortical Thinning Associated with Cognitive Deterioration in Parkinson’s Disease
Javier Pagonabarraga, Idoia Corcuera-Solano, Yolanda Vives-Gilabert et al. · PLoS ONE · 2013
Full textCC BY